Rexulti OD tablets 1mg from Otsuka Pharmaceutical contains brexpiprazole, an atypical antipsychotic used to treat schizophrenia, as an adjunctive therapy for major depressive disorder, and agitation associated with dementia due to Alzheimer’s disease. The YJ code is 1179058F4020, with a standard of 1mg per tablet.
Rexulti OD tablets 1mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).
